Related Experiment Video
Updated: May 22, 2026

Stimulus-specific Cortical Visual Evoked Potential Morphological Patterns
Published on: May 12, 2019
Cyclic Vomiting Syndrome (CVS): is there a difference based on onset of symptoms--pediatric versus adult?
Nilay Kumar1, Qumseya Bashar, Naveen Reddy
1Department of Gastroenterology and Hepatology, Medical College of Wisconsin, 4th Floor, Froedtert East Building, 9200 W Wisconsin Avenue, Milwaukee, WI 53226, USA.
Insights
Cyclic Vomiting Syndrome (CVS) in adults and children share similar clinical features and treatment responses, with most patients benefiting from standard therapies. Patient compliance is key to successful treatment outcomes for this functional gastrointestinal disorder.
Area of Science:
- Gastroenterology
- Pediatrics
- Genetics
Background:
- Cyclic Vomiting Syndrome (CVS) is recognized in children but poorly understood in adults.
- Recent studies suggest genetic differences between pediatric- and adult-onset CVS.
- Clinical features and treatment response differences remain understudied.
Purpose of the Study:
- To compare clinical features and treatment responses in pediatric-onset versus adult-onset CVS.
- To identify factors influencing treatment outcomes in CVS patients.
Main Methods:
- Retrospective review of 101 CVS patients diagnosed using Rome III criteria.
- Comparison of clinical characteristics and treatment outcomes between pediatric-onset (<18 years) and adult-onset CVS groups.
Main Results:
- Pediatric-onset CVS patients were more likely to be female and had a higher prevalence of CVS plus.
- Longer diagnostic delays were observed in the pediatric-onset group.
- Most patients (86%) responded to standard therapies (tricyclic antidepressants, anticonvulsants, CoQ10, L-carnitine).
- Patient compliance was the only significant factor associated with treatment response on multivariate analysis.
Conclusions:
- Clinical features and response to standard therapy are largely similar between pediatric- and adult-onset CVS.
- Most CVS patients respond well to treatment.
- Patient compliance is crucial for successful CVS management.
Background:
Cyclic Vomiting Syndrome (CVS) is a well-recognized functional gastrointestinal disorder in children but its presentation is poorly understood in adults. Genetic differences in pediatric-onset (presentation before age 18) and adult-onset CVS have been reported recently but their clinical features and possible differences in response to therapy have not been well studied.
Methods:
This was a retrospective review of 101 CVS patients seen at the Medical College of Wisconsin between 2006 and 2008. Rome III criteria were utilized to make the diagnosis of CVS.
Results:
Our study population comprised of 29(29%) pediatric-onset and 72 (71%) adult-onset CVS patients. Pediatric-onset CVS patients were more likely to be female (86% vs. 57%, p = 0.005) and had a higher prevalence of CVS plus (CVS + neurocognitive disorders) as compared to adult-onset CVS patients (14% vs. 3%, p = 0.05). There was a longer delay in diagnosis (10 ± 7 years) in the pediatric-onset group when compared to (5 ± 7 years) adult-onset CVS group (p = 0.001). Chronic opiate use was less frequent in the pediatric-onset group compared to adult-onset patients (0% vs. 23%, p = 0.004). Aside from these differences, the two groups were similar with regards to their clinical features and the time of onset of symptoms did not predict response to standard treatment. The majority of patients (86%) responded to treatment with tricyclic antidepressants, anticonvulsants (topiramate), coenzyme Q-10, and L-carnitine. Non-response to therapy was associated with coalescence of symptoms, chronic opiate use and more severe disease as characterized by longer episodes, greater number of emergency department visits in the year prior to presentation, presence of disability and non-compliance on univariate analysis. On multivariate analysis, only compliance to therapy was associated with a response. (88% vs. 38%, Odds Ratio, OR 9.6; 95% Confidence Interval [CI], 1.18-77.05).
Conclusion:
Despite reported genetic differences, the clinical features and response to standard therapy in pediatric- and adult-onset CVS were mostly similar. Most patients (86%) responded to therapy and compliance was the only factor associated with a response.
Related Concept Videos
Pathophysiology of Vomiting
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Equilibrium and Balance
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Voltammetric Techniques: Cyclic Voltammetry
Pyloric Obstruction